Circular RNA CircSLC22A23 Promotes Gastric Cancer Progression by Activating HNRNPU Expression

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2024 Feb 24

PMID 38400886

Authors

Xinxin Wu

Chunli Cao

Zhe Li

Yaoyao Xie

Shuangshuang Zhang

Weiliang Sun

Junming Guo

Affiliations

Soon will be listed here.

Abstract

Background: Circular RNAs (CircRNAs) play essential roles in cancer occurrence as regulatory RNAs. However, circRNA-mediated regulation of gastric cancer (GC) remains poorly understood.

Aim: The purpose of this study was to investigate the molecular mechanism of circSLC22A23 (hsa_circ_0075504) underlying GC occurrence.

Methods: CircSLC22A23 levels were first quantified by quantitative real-time reverse transcription-polymerase chain reaction in GC cell lines, 80 paired GC tissues and adjacent normal tissues, and 27 pairs of plasma samples from preoperative and postoperative patients with GC. Then circSLC22A23 was knocked-down with short hairpin RNA to analyze its oncogenic effects on the proliferation, migration, and invasion of GC cells. Finally, circRNA-binding proteins and their downstream target genes were identified by RNA pulldown, mass spectrometry, RNA immunoprecipitation, quantitative real-time reverse transcription-polymerase chain reaction, and Western blot assays.

Results: CircSLC22A23 was found to be highly expressed in GC cells, GC tissues, and plasma from GC patients. Knockdown of circSLC22A23 inhibited GC cell proliferation, migration and invasion. RNA pulldown and RNA immunoprecipitation assays verified the interaction between circSLC22A23 and heterogeneous nuclear ribonucleoprotein U (HNRNPU). Knockdown of circSLC22A23 decreased HNRNPU protein levels. Moreover, rescue assays showed that the tumor suppressive effect of circSLC22A23 knockdown was reversed by HNRNPU overexpression. Finally, epidermal growth factor receptor (EGFR) was found to be one of the downstream target genes of HNRNPU that was up regulated by circSLC22A23.

Conclusion: CircSLC22A23 regulated the transcription of EGFR through activation of HNRNPU in GC cells, suggesting that circSLC22A23 may serve as a potential therapeutic target for the treatment of GC.

References

Alsina M, Arrazubi V, Diez M, Tabernero J . Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2022; 20(3):155-170. DOI: 10.1038/s41575-022-00703-w. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Lopez M, Carbajal J, Alfaro A, Saravia L, Zanabria D, Araujo J . Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2022; 181:103841. DOI: 10.1016/j.critrevonc.2022.103841. View

Peng Y, Xu Y, Zhang X, Deng S, Yuan Y, Luo X . A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression. Mol Cancer. 2021; 20(1):158. PMC: 8642992. DOI: 10.1186/s12943-021-01457-w. View

Kristensen L, Andersen M, Stagsted L, Ebbesen K, Hansen T, Kjems J . The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019; 20(11):675-691. DOI: 10.1038/s41576-019-0158-7. View

Li J, Sun D, Pu W, Wang J, Peng Y . Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. Trends Cancer. 2020; 6(4):319-336. DOI: 10.1016/j.trecan.2020.01.012. View

Li Z, Xie Y, Xiao B, Guo J . The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway. Int J Clin Oncol. 2022; 27(10):1562-1569. DOI: 10.1007/s10147-022-02210-z. View

Liu C, Chen L . Circular RNAs: Characterization, cellular roles, and applications. Cell. 2022; 185(12):2016-2034. DOI: 10.1016/j.cell.2022.04.021. View

Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y . Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis. 2020; 11(2):145. PMC: 7039970. DOI: 10.1038/s41419-020-2336-0. View

10.

Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C . circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019; 10(1):3200. PMC: 6642174. DOI: 10.1038/s41467-019-11162-4. View

11.

Wang X, Chen M, Fang L . hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3. Mol Ther Nucleic Acids. 2021; 26:122-134. PMC: 8413675. DOI: 10.1016/j.omtn.2021.07.003. View

12.

Chen J, Wu Y, Luo X, Jin D, Zhou W, Ju Z . Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer. Theranostics. 2021; 11(15):7507-7526. PMC: 8210600. DOI: 10.7150/thno.59546. View

13.

Sun Y, Wang W, Zeng Z, Chen T, Han C, Pan Q . circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019; 134(18):1533-1546. PMC: 6839953. DOI: 10.1182/blood.2019000802. View

14.

Chen R, Wang S, Belk J, Amaya L, Li Z, Cardenas A . Engineering circular RNA for enhanced protein production. Nat Biotechnol. 2022; 41(2):262-272. PMC: 9931579. DOI: 10.1038/s41587-022-01393-0. View

15.

Fan X, Yang Y, Chen C, Wang Z . Pervasive translation of circular RNAs driven by short IRES-like elements. Nat Commun. 2022; 13(1):3751. PMC: 9242994. DOI: 10.1038/s41467-022-31327-y. View

16.

Cai Y, Zhao X, Chen D, Zhang F, Chen Q, Shao C . circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4. Mol Ther Nucleic Acids. 2021; 26:773-786. PMC: 8526500. DOI: 10.1016/j.omtn.2021.09.013. View

17.

Liu M, Lai M, Li D, Zhang R, Wang L, Peng W . Nucleus-localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG transcription. Cancer Sci. 2023; 114(10):3884-3899. PMC: 10551608. DOI: 10.1111/cas.15906. View

18.

Zhao Z, Yang W, Kong R, Zhang Y, Li L, Song Z . circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer. Mol Cancer. 2023; 22(1):152. PMC: 10492306. DOI: 10.1186/s12943-023-01847-2. View

19.

Shi Z, Hao L, Han X, Wu Z, Pang K, Dong Y . Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022; 21(1):37. PMC: 8819945. DOI: 10.1186/s12943-022-01517-9. View

20.

Li R, Jiang J, Shi H, Qian H, Zhang X, Xu W . CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2019; 77(9):1661-1680. PMC: 11104848. DOI: 10.1007/s00018-019-03345-5. View